AzTrials
AzTrials

TechnologyNCT05404802

Therapeutic Effectiveness of PARO Companion Robot for Elderly With Mild Cognitive Impairment/Dementia in Elderly Residential Setting: A Quasi-experimental Study

A study testing Experimental group intervention in people with Technology, run by The University of Hong Kong at 2 sites in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main trial is a 2-group quasi-experimental trial of comparing the outcome indicators between joining and not joining the 10-week personal assistive robot (PARO) training program in residents with dementia or mild cognitive impairment (MCI). The study questions are as follows: Primary study questions: i. Read more about this study

Who is it for?
Any age
Conditions the study is for
Technology
What is being tested?
Experimental group intervention
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
37 participants
Where
2 sitesHong Kong
Study dates
20 Jun 2022to 13 Oct 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Is diagnosed with mild to moderate dementia by doctors
  • Score at least 5 (Pan et al., 2020) and lower than the norm-derived age and education adjusted cutoff scores 7th percentile in HK-MoCA (Wong et al., 2015), non-dementia patients
  • Have participated in the main trial
  • Able to verbally communicate in Cantonese as perceived by the staff of the related home

Who cannot join

  • Have unstable physical or psychological conditions as advised by doctors or nurse in charge
  • Have severe medical conditions which limit the ability to participate in the PARO sessions
  • Have visual or hearing impairment that interfere with cognitive intervention
  • Fear or reluctance in using robots
  • Unable to communicate
  • None
Show all 10Show fewer
  • Inclusion Criteria of PARO facilitator for qualitative interviews:
  • Have participated in the main trial
  • Exclusion Criteria for PARO facilitator in qualitative interviews:
  • None

Trial locations and contacts

2 sites in 1 country.

Hong Kong2 sites
  • Haven of Hope Hang Hau Care and Attention Home for Severely Disabled

    Hong Kong, 00

  • Haven of Hope Woo Ping Care & Attention Home

    Hong Kong, 00

Other trials in Hong Kong

About this study

The main trial is a 2-group quasi-experimental trial of comparing the outcome indicators between joining and not joining the 10-week personal assistive robot (PARO) training program in residents with dementia or mild cognitive impairment (MCI). The study questions are as follows:

Primary study questions:

Read more
  1. Can participation of the 10-week PARO training program reduce neuropsychiatric symptoms at week 10? ii. Can participation of the 10-week PARO training program reduce loneliness at week 10?

Secondary study questions:

iii. Can participation of PARO training session reduce pulse rate (as an indicator of stress and anxiety)?

iv. Can participation of PARO training session improve oxygen saturation (as an indicator of stress and anxiety)?

  1. What are the participants' emotions and engagement in PARO training sessions?

Auxiliary study questions:

vi. Can participation of the 10-week PARO training program reduce neuropsychiatric symptoms at week 14?

vii. Can participation of the 10-week PARO training program reduce loneliness at week 14?

viii. Can participation of the 10-week PARO training program improve quality of life at week 10?

ix. Can participation of the 10-week PARO training program improve quality of life at week 14?

  1. Can participation of the 10-week PARO training program improve sleep quality at week 10? xi. Can participation of the 10-week PARO training program improve sleep quality at week 14? xii. Can participation of the 10-week PARO training program improve cognitive functioning at week 10? xiii. Can participation of the 10-week PARO training program improve cognitive functioning at week 14? xiv. What are the feelings, satisfaction, and acceptance of PARO of the participants and PARO facilitators?
Read the detailed description

Study design

This is a 2-group quasi-experimental trial of comparing the outcome indicators between joining and not joining the 10-week PARO training program in residents with dementia or mild cognitive impairment (MCI) in Haven of Hope Woo Ping Care \& Attention Home. Residents from the Haven of Hope Hang Hau Care and Attention Home for Severely Disabled will also be recruited and join the PARO training program, but their data will be analysed independently. The feelings, satisfaction, and acceptance of PARO of the participants and PARO facilitators.

Procedures

Training of PARO facilitators

Nurses, social workers, occupational therapists, health care assistants and program workers of the service units will be recruited and trained as PARO facilitators. The formal PARO facilitator training lasts for about 3 hours. An intervention protocol will be provided for the facilitators in running the training sessions.

Participants' recruitment and consent

In the residential care homes under Haven of Hope Christian Service (HOHCS), the care staff and nurses will check the eligibility of the elderly and invite eligible participants to join the trial. Residents scoring above the cutoff for dementia in Montreal Cognitive Assessment (MoCA) and not receiving a medical diagnosis of dementia or other mentally incapacitating disease will be classified as competent in giving consent. For residents scoring below the cutoff in MoCA or receiving a diagnosis of mentally incapacitating disease, we will follow the criteria stated in the Alzheimer Europe Report (2011) to ensure that they are provided chances to give consent. In particular, four criteria will be evaluated, including 1) the person must have sufficient capacity to understand the information, 2) the person is able to retain, use and weight up such information for making a decision, 3) the person will understand the benefit, risk, and convenience, 4) the person must have the ability to communicate the decision. The University of Hong Kong (HKU) research staff and the care staff will first commit them in a causal chat to assess their ability to communicate and understand the dialogues.

If residents are competent in giving consent, both residents and their family members, will be approached for consent. In cases residents are not competent in giving consents, only their family members will be approached for consent. They will then be referred to join a 1-to-1 study introduction session. In this session, HKU research staff and service unit staff will introduce the study to the participant, and invite them to sign a consent form.

After the consent is obtained, the HKU research staff will assist the participant to complete the UCLA 3-Item Loneliness Scale (UCLA 3-item), Mini-Mental State Examination (MMSE), the 5-level EQ-5D version (EQ-5D-5L), and Insomnia Severity Index (ISI), and assist the care staff to complete Neuropsychiatric Inventory Questionnaire (NPI-Q). Participants will be allocated to the experimental group or the control group according to their floor of the residential care homes. The participants in the experimental group will be arranged to join the PARO intervention in Week 1 to 10. The control group will be arranged to attend 2 PARO training sessions after all assessments are completed. As a voluntary participation, the participants have the right to withdraw from the study and intervention any time without consequences.

Interventions

Training sessions for experimental group

Each session aims to facilitate engagement, communication and interaction with the robots and other participants. Each session will take place for 30-45 minutes, twice a week over a 10-week period. Each session will be attended by a cluster of 4 to 6 participants. In each session, several activities with PARO will be supervised by the facilitator including baby-sitting PARO, feeding PARO, grooming PARO, etc. The first session will be used as a pilot run to revise our test protocol. The first three group sessions will be primarily focused on enhancing the intimacy between the group participants and their therapeutic relationship with the PARO companion robot. Participants will be introduced with the PARO training program and each other, followed by naming PARO. Fun activities such as informing each other of one's Chinese zodiac and animal's name matching game will be used to develop their friendliness and rapport towards PARO. In the third session, the facilitators will show seal photos and videos (*subject to the availability of audio-visual (AV) equipment in the care homes) so that participants will be able to recognise PARO.

Facilitators will facilitate participants' interaction with PARO for 7 main activities, namely: (1) hugging PARO: (1a) touching and hugging PARO; (1b) comparing PARO with a pet; (2) expressing emotions to PARO: (2a) selecting seven emotional stickers and talking about emotions; (2b) observing positive/negative reactions of PARO; (3) remembering PARO: (3a) talking about PARO's name and seal; (3b) becoming accustomed to PARO's movements, noises, etc; (4) feeding PARO: (4a) searching animal's feed, (4b) sharing food and snacks, (4c) feeding PARO; (5) sleeping PARO: (5a) sing favourite song or singing and clapping song, (5b) putting PARO to sleep with a cradle song; (6) bathing PARO: (6a) cleaning hands, (6b) cleaning PARO, (6c) combing PARO's hair; (7) decorating PARO: (7a) decorating PARO with ribbon, scarf, cap, etc., (7b) decorating oneself with favourite things.

Free-play sessions

For the experimental group, during the 10-week training program, to increase the exposure of participants in experimental group to PARO, two 15-30 minutes free-play sessions in each week are conducted on days when there are no training sessions. In these sessions, every participant can interact with one PARO without instructions but are under the safety supervision of a PARO facilitator.

Intervention for control group

Control group will receive no PARO-related intervention from week 1 to week 10. They will attend 2 training sessions after all assessments are completed. Activity content in these training sessions will be similar to those for the experimental group.

Data collection

HKU research staff who are blinded to the group allocation will administer all the questionnaires at baseline, 10-week and 14-week. For experimental group, after each training session and free-play session, PARO facilitators will complete Engagement of a Person with Dementia Scale (EPDS) for every participant. After each training session, they will complete two items about compliance and non-compliance with instructions for every participant. There were three selected training sessions in every cluster in the beginning phase, middle phase and ending phase that biomarkers will be collected and process observed by HKU senior research assistant. The biomarkers of pulse rate and oxygen saturation of the participants (as an indicator of feelings of stress and anxiety) will be measured using pulse oximeter before and after each of the three selected training sessions. The emotions of every participant and any special events during the three selected training sessions will be documented by HKU senior research assistant using Observed Emotion Rating Scale (OERS). To reduce the possible impacts brought by the presence of research team, the observer will introduce himself before and after the residents move to the activity room. Also, the observer will not interfere into the training activities.

In case of events (e.g. COVID-19) that prohibit HKU research staff to conduct assessment on site, assessment will be conducted via online communication apps (e.g. Zoom), and processes of training sessions will be video-recorded,

Qualitative interview

To collect feedback towards the PARO companion robot intervention, we will use purposive sampling to select 10 participants and at most 6 facilitators to conduct semi-structured qualitative interviews to collect opinion on their satisfaction and perceived acceptance on PARO features. An interview guide with open-ended and iterative questions will be used to probe for more experiences from the interviewees. Each interview will be conducted by a trained research assistant and will last about 30 minutes.

Blinding

Participants, training session moderators and observers of PARO sessions cannot and will not be blinded to the intervention. Assessors of the follow-up outcomes and the research analysts will not be involved in the recruitment and intervention delivery and will be blinded to the group allocation (single blindness).

Sample size determination

The sample size is estimated by the current number of dementia/MCI residents in the test sites. In the Woo Ping Care \& Attention Home, 52 residents have been diagnosed dementia/MCI. In the Care and Attention Home for Severely Disabled, 5 have been diagnosed. Therefore, the study will include 57 residents in total.

Data analyses

Main analysis

Linear mixed model analysis will be used to test the interaction between group and time. A partial-eta square will be used to estimate the effect size of the outcome indicators in comparing the intervention group with the control group.

Process evaluations

For the biomarkers, linear mixed model analysis will be used to test the interaction between group and time. A partial-eta square will be used to estimate the effect size of the outcome indicators in comparing the intervention group with the control group. For the rated scales, descriptive statistics will be used to show the changes of emotions and incidence of negative emotions.

Qualitative interview

The interview content will be transcribed verbatim in Chinese for further analysis. We will analyze the qualitative interview transcripts using framework analysis to construct a coherent and logical structure from the classification of many opinions and perceptions of the PARO training program. The results will then be discussed and consolidated in the panel meetings with the co-authors.

Conditions
Technology
Being tested
Experimental group intervention, Control group intervention
Keywords
Gerontechnology, Smart Healthcare Device, Digital Health Technology

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Experimental group interventionDevice

    Training session

    Facilitators will facilitate participants' interaction with PARO for 7 main activities, namely: (1) hugging PARO; (2) expressing emotions to PARO: (3) remembering PARO; (4) feeding PARO; (5) sleeping PARO; (6) bathing PARO; (7) decorating PARO.

    Free-play session

    In these sessions, every participant can interact with one PARO without instructions but are under the safety supervision of a PARO facilitator.

  • Control group interventionDevice

    Facilitators will facilitate participants' interaction with PARO for 7 main activities, namely: (1) hugging PARO; (2) expressing emotions to PARO: (3) remembering PARO; (4) feeding PARO; (5) sleeping PARO; (6) bathing PARO; (7) decorating PARO.

Study groups in NCT05404802
Study groupRoleWhat they receive
Experimental GroupExperimentalTraining sessions Each training session will last for 30-45 minutes, twice a week over a 10-week period in Week 1 to Week 10. Each session will be attended by a cluster of 4 to 6 participants, and each participant will have one PARO. Free-play sessions Two 15-30 minutes free-play sessions in each week of the 10 weeks are conducted on days when there are no training sessions.
Receives: Device: Experimental group intervention
Control GroupExperimentalTraining sessions Each training session will last for 30-45 minutes, once a week over a 2-week period after all assessments are completed. Each session will be attended by a cluster of 4 to 6 participants, and each participant will have one PARO. There is no free-play sessions for control group.
Receives: Device: Control group intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 10 week change in neuropsychiatric symptoms after participating in 10-week PARO training program

    Change of neuropsychiatric symptoms after participating in 10-week PARO training program will be measured by Neuropsychiatric Inventory Questionnaire (NPI-Q; Cummings, et al., 1994; Kauffer, 1999). The range of the the severity scale is 12 to 36, with higher score indicating more severe neuropsychiatric symptoms. The range of the caregiver distress scale is 0 to 60, with higher score indicating higher caregiver distress.

    Measured: Baseline and the 10th week

  2. 10 week change in loneliness after participating in 10-week PARO training program

    Change of loneliness after participating in 10-week PARO training program will be measured by UCLA Loneliness Scale 3 items (UCLA 3-items, Russell et al., 1980; Liu et al., 2020). The minimum and maximum values of the scale are 3 and 9 respectively, with higher score indicating higher level of loneliness.

    Measured: Baseline and the 10th week

Secondary outcomes (12)
  1. Change in feelings of stress and anxiety as indicated by pulse rate after participating in PARO training session

    The change of feelings of stress and anxiety after participating in PARO training session will be measured by pulse rate.

    Measured: Before and after the three training sessions during the 10-week trial period

  2. Change in feelings of stress and anxiety as indicated by oxygen saturation after participating in PARO training session

    The change of feelings of stress and anxiety after participating in PARO training session will be measured by oxygen saturation

    Measured: Before and after the three training sessions during the 10-week trial period

  3. Qualitative Measure: Observed emotions

    Emotions will serve as an indicator of satisfaction and acceptance of PARO, and will be observed in PARO training session using Observed Emotion Rating Scale (OERS; Lawton et al., 1999). Under the scale, the 5 emotions of pleasure, general alertness, anxiety/ fear, anger, and sadness are observed. The minimum and maximum values of each coding for 10 minutes observation are 1 and 5 respectively, with higher score indicating longer duration of the observed emotion within the 10 minute period.

    Measured: 3 PARO training sessions during the 10-week trial period

  4. Qualitative Measure: Observed engagement

    Engagement will serve as an indicator of satisfaction and acceptance of PARO. After each training session and free-play session, PARO facilitators will complete Engagement of a Person with Dementia Scale (EPDS; Jones et al., 2018) for every participant. The minimum and maximum values of EPDS are 10 and 50 respectively, with higher score indicating higher level of positive engagement exhibited.

    Measured: Every PARO training session and every free-play session during the 10-week trial period

  5. Qualitative Measure: Observed engagement (compliance)

    Compliance will serve as an indicator of engagement, satisfaction and acceptance of PARO. After each training session and free-play session, PARO facilitators will complete two items about compliance and non-compliance with instructions for every participant. The minimum and maximum values of the sum of the two items are 2 and 10 respectively, with higher score indicating higher compliance.

    Measured: Every PARO training session during the 10-week trial period

  6. 14 week change in neuropsychiatric symptoms after participating in 10-week PARO training program

    Change of neuropsychiatric symptoms after participating in 10-week PARO training program will be measured by Neuropsychiatric Inventory Questionnaire (NPI-Q; Cummings, et al., 1994; Kauffer, 1999). The range of the the severity scale is 12 to 36, with higher score indicating more severe neuropsychiatric symptoms. The range of the caregiver distress scale is 0 to 60, with higher score indicating higher caregiver distress.

    Measured: Baseline and 14th week

  7. 14 week change in loneliness after participating in 10-week PARO training program

    Change of loneliness after participating in 10-week PARO training program will be measured by UCLA Loneliness Scale 3 items (UCLA 3-items, Russell et al., 1980; Liu et al., 2020). The minimum and maximum values of the scale are 3 and 9 respectively, with higher score indicating higher level of loneliness.

    Measured: Baseline and 14th week

  8. Change in quality of life after participating in 10-week PARO training program

    The change of quality of life after participating in 10-week PARO training program will be measured by 5-level EQ-5D (EQ-5D-5L; Wong et al., 2018). Using the algorithm based on Hong Kong population, the minimum and maximum utility values of the scale are -0.803 and 1 respectively, with higher score indicating better quality of life.

    Measured: Baseline, the 10th week and 14th week

  9. Change in sleep quality after participating in 10-week PARO training program

    The change of sleep quality after participating in 10-week PARO training program will be measured by Insomnia Severity Index (ISI; Morin 1993; Yu, 2010). The minimum and maximum values of the scale are 0 and 16 respectively, with higher score indicating higher insomnia severity.

    Measured: Baseline, the 10th week and 14th week

  10. Change in cognitive functions after participating in 10-week PARO training program

    The change of cognitive functions of after participating in 10-week PARO training program will be measured by Mini-Mental State Examination (MMSE; Folstein et al., 1975). The minimum and maximum values of the scale are 0 and 30 respectively, with higher score indicating higher level of cognitive functioning.

    Measured: Baseline, the 10th week and 14th week

  11. Qualitative Measure: Perceived feelings, satisfaction and acceptance on companion robot by the participants

    The participants answer the following question in semi-structured qualitative interviews:

    1. Do you like (the name of the robot)?
    2. What do you like about (the name of the robot)?
    3. Did (the name of the robot) do something you dislike?
    4. Is there anything you dislike about (the name of the robot)?
    5. How do you feel with the company of (the name of the robot)?
    6. What do you do with (the name of the robot) regularly?
    7. Do you wish to spend more time (the name of the robot)?
    8. Under what circumstances, do you need the company of (the name of the robot)
    9. Do you wish or need others to spend time with (the name of the robot) and you?
    10. To conclude, are you satisfied or dissatisfied with (the name of the robot)?
    11. Do you wish to see it again?

    Measured: within 2 weeks after week 10

  12. Qualitative Measure: Perceived feelings, satisfaction and acceptance on companion robot by the PARO facilitators

    The PARO facilitators answer the following questions in semi-structured qualitative interviews:

    1. Were the companion robots safe?
    2. Was it easy or difficult to use the companion robots?
    3. Did you expect the participants to accept the companion robots?
    4. What types of participants are more likely and less likely to accept the companion robots?
    5. When are the participants more willing to interact with the companion robots?
    6. What do you suggest to improve the acceptability of the companion robots?
    7. Is the training on companion robots sufficient?
    8. What did you expect to be the benefits and concerns of the companion robots?
    9. Did you find these benefits and concerns?
    10. Were there any unexpected benefits and concerns?
    11. What are your suggestions to the staff who will use the companion robots?
    12. Are you satisfied or dissatisfied with the companion robots?
    13. Do you want to use the companion robots in the future?
    14. Are companion robots cost-effective?

    Measured: within 2 weeks after week 10

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jun 2022
  2. Study start20 Jun 2022
  3. Primary completion9 Sep 2022
  4. Study completion13 Oct 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Participants will be allocated to the experimental group or the control group according to their floor of the residential care homes. The participants in the experimental group will be arranged to join the PARO intervention in Week 1 to 10. The control group will be arranged to attend 2 PARO training sessions after all assessments are completed.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
37 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05404802
Sponsor's protocol ID
HKU_robot_protocol_v3
Status last verified
Mar 2023
First submitted
26 May 2022
Last updated
6 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Research data and documentation will be available upon request.

Publications

  • Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98. doi: 10.1016/0022-3956(75)90026-6. No abstract available.

    PubMed 1202204
  • Jones C, Sung B, Moyle W. Engagement of a Person with Dementia Scale: Establishing content validity and psychometric properties. J Adv Nurs. 2018 May 17. doi: 10.1111/jan.13717. Online ahead of print.

    PubMed 29772602
  • Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, Lopez OL, DeKosky ST. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):233-9. doi: 10.1176/jnp.12.2.233.

    PubMed 11001602
  • Lawton MP, Van Haitsma K, Klapper J. Observed affect in nursing home residents with Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci. 1996 Jan;51(1):P3-14. doi: 10.1093/geronb/51b.1.p3.

    PubMed 8548515
  • Pan IMY, Lau MS, Mak SC, Hariman KW, Hon SKH, Ching WK, Cheng KM, Chan CF. Staging of Dementia Severity With the Hong Kong Version of the Montreal Cognitive Assessment (HK-MoCA)'s. Alzheimer Dis Assoc Disord. 2020 Oct-Dec;34(4):333-338. doi: 10.1097/WAD.0000000000000399.

    PubMed 32701514
  • Piau A, Campo E, Rumeau P, Vellas B, Nourhashemi F. Aging society and gerontechnology: a solution for an independent living? J Nutr Health Aging. 2014 Jan;18(1):97-112. doi: 10.1007/s12603-013-0356-5.

    PubMed 24402399
  • Russell DW. UCLA Loneliness Scale (Version 3): reliability, validity, and factor structure. J Pers Assess. 1996 Feb;66(1):20-40. doi: 10.1207/s15327752jpa6601_2.

    PubMed 8576833
  • Wong A, Law LS, Liu W, Wang Z, Lo ES, Lau A, Wong LK, Mok VC. Montreal Cognitive Assessment: One Cutoff Never Fits All. Stroke. 2015 Dec;46(12):3547-50. doi: 10.1161/STROKEAHA.115.011226. Epub 2015 Oct 15.

    PubMed 26470772
  • Carmeli E. Aspects of assistive gerontechnology. Int J Disabil Hum Dev. 2009; 8(3): 215-218.

  • Liu T, Lu S, Leung DKY, Sze LCY, Kwok WW, Tang JYM, Luo H, Lum TYS, Wong GHY. Adapting the UCLA 3-item loneliness scale for community-based depressive symptoms screening interview among older Chinese: a cross-sectional study. BMJ Open. 2020 Dec 10;10(12):e041921. doi: 10.1136/bmjopen-2020-041921.

    PubMed 33303463
  • Yu DS. Insomnia Severity Index: psychometric properties with Chinese community-dwelling older people. J Adv Nurs. 2010 Oct;66(10):2350-9. doi: 10.1111/j.1365-2648.2010.05394.x. Epub 2010 Aug 16.

    PubMed 20722803
  • Morin CM. Insomnia: psychological assessment and management. Guilford press. 1993.

  • Wong ELY, Ramos-Goni JM, Cheung AWL, Wong AYK, Rivero-Arias O. Assessing the Use of a Feedback Module to Model EQ-5D-5L Health States Values in Hong Kong. Patient. 2018 Apr;11(2):235-247. doi: 10.1007/s40271-017-0278-0.

    PubMed 29019161

Questions about this trial

What is this clinical trial studying?

A study testing Experimental group intervention in people with Technology, run by The University of Hong Kong at 2 sites in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

10 week change in neuropsychiatric symptoms after participating in 10-week PARO training program (time frame: Baseline and the 10th week). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05404802, which also lists 13 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Mar 2023; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in